Loading company…
TRiCares develops the Topaz catheter-based tricuspid valve replacement system for patients with tricuspid regurgitation.
Founded in 2013 and headquartered in Paris, France, TRiCares SAS sells the Topaz device, a minimally invasive catheter-based tricuspid valve replacement system, to hospitals and medical centers. Its target markets include the United States, Europe and Brazil, and revenue depends on device purchases and potential supply partnerships. The company completed a Series D funding round in July 2024 to support the Topaz heart valve and upcoming clinical milestones.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in